波立维联合瑞舒伐他汀治疗不稳定型心绞痛的临床疗效分析

Analysis on the Clinical Efficacy of Plavix Combined with Rosuvastatin in the Treatment of Unstable Angina

目的分析波立维联合瑞舒伐他汀治疗不稳定型心绞痛的临床疗效。方法选取我院2013年1月至2018年1月收治的114例不稳定型心绞痛患者,随机分为观察组和对照组各57例。对照组给予常规治疗,观察组在常规基础上给予波立维联合瑞舒伐他汀治疗,比较两组患者的治疗效果。结果治疗后,观察组的心绞痛发作频率和持续时间均显著低于对照组, TC、 TG、LDL-C水平显著低于对照组, HDL-C水平显著高于对照组(均P <0.01)。观察组的治疗总有效率为96.49%,显著高于对照组的78.95%(P <0.05)。结论波立维联合瑞舒伐他汀治疗不稳定型心绞痛疗效显著,可有效改善患者的临床症状,调节血脂水平。

Objective To analyze the clinical efficacy of Plavix combined with rosuvastatin in the treatment of unstable angina. Methods 114 cases of patients with unstable angina admitted to our hospital from January 2013 to January 2018 were randomly divided into the observation group and the control group, with 57 cases in each group. The control group was given routine treatment, while the observation group was given Plavix combined with rosuvastatin on the basis of routine treatment. The curative effects of the two groups were compared. Results After treatment, the frequency and duration of angina pectoris of the observation group were significantly lower than those of the control group, the levels ofTC, TG and LDL-C were significantly lower than those of the control group, and the level of HDL-C was significantly higher than that of the control group （P 〈0.01）. The total effective rate of treatment of the observation group was 96.49%, significantly higher than 78.95% ofthe control group （P〈0.05）. Conclusions Plavix combined with rosuvastatin inthe treatment ofunstable angina has significant efficacy, which can effectively improve the clinical symptoms, and regulate the blood lipid levels of patients.